Evidence map›Paper›PMID 28670072›Full record

ArticleProceedings (Baylor University. Medical Center)2017

Primary mucoepidermoid carcinoma of the lung with prominent clear cells.

David D Fink, Angela M Lomas, Anja C Roden, Prashant C Shah, Riyam T Zreik

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David D FinkDepartments of Pathology (Fink, Zreik) and Surgery (Shah), Scott & White Medical Center, Temple, Texas; Texas A&M College of Medicine, Temple, Texas (Lomas); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden).
Angela M LomasDepartments of Pathology (Fink, Zreik) and Surgery (Shah), Scott & White Medical Center, Temple, Texas; Texas A&M College of Medicine, Temple, Texas (Lomas); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden).
Anja C RodenDepartments of Pathology (Fink, Zreik) and Surgery (Shah), Scott & White Medical Center, Temple, Texas; Texas A&M College of Medicine, Temple, Texas (Lomas); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden).
Prashant C ShahDepartments of Pathology (Fink, Zreik) and Surgery (Shah), Scott & White Medical Center, Temple, Texas; Texas A&M College of Medicine, Temple, Texas (Lomas); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden).
Riyam T ZreikDepartments of Pathology (Fink, Zreik) and Surgery (Shah), Scott & White Medical Center, Temple, Texas; Texas A&M College of Medicine, Temple, Texas (Lomas); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden).
Temple College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucoepidermoid carcinoma of the lung is a rare malignancy of salivary gland-type origin. We report a case of a 21-year-old man with a right mainstem bronchus mass composed predominantly of clear cells. This case represents a rare primary pulmonary low-grade mucoepidermoid carcinoma positive for

Identifiers

PMID28670072
PMCPMC5468030
OpenAlexW2774846662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.